Samuel Backenroth

Insider Reports History

Location
New York, NY
Signature
/s/ Samuel Backenroth
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Samuel Backenroth:

Company Role Class Num Shares Value Price $ Report Date Ownership
Vascular Biogenics Ltd. Chief Financial Officer Ordinary Shares 525,000 31 Mar 2023 Direct
Vascular Biogenics Ltd. Chief Financial Officer Restricted Stock Units 175,000 31 Mar 2023 Direct

Insider Reports Filed by Samuel Backenroth

Symbol Company Period Transactions Value $ Form Type Role Filing Time
/report/000149315223012789-backenroth-samuel-2023-03-31 Vascular Biogenics Ltd. 31 Mar 2023 2 $0 4 Chief Financial Officer 18 Apr 2023, 16:36
/report/000149315223000180-backenroth-samuel-2023-01-01 Vascular Biogenics Ltd. 01 Jan 2023 0 $0 3 Chief Financial Officer 03 Jan 2023, 20:04